Published in Trop Med Int Health on May 10, 2013
Impact of community-based interventions for the prevention and control of malaria on intervention coverage and health outcomes for the prevention and control of malaria. Infect Dis Poverty (2014) 0.95
Climate influences on the cost-effectiveness of vector-based interventions against malaria in elimination scenarios. Philos Trans R Soc Lond B Biol Sci (2015) 0.81
Impact of cotrimoxazole and insecticide-treated nets for malaria prevention on key outcomes among HIV-infected adults in low- and middle-income countries: a systematic review. J Acquir Immune Defic Syndr (2015) 0.75
Are long-lasting insecticide-treated bednets and water filters cost-effective tools for delaying HIV disease progression in Kenya? Glob Health Action (2015) 0.75
HIV prevention before HAART in sub-Saharan Africa. Lancet (2002) 5.55
Public health. Reassessing HIV prevention. Science (2008) 4.06
Costs and financial feasibility of malaria elimination. Lancet (2010) 3.15
HIV prevention costs and program scale: data from the PANCEA project in five low and middle-income countries. BMC Health Serv Res (2007) 2.55
Expanding ART for treatment and prevention of HIV in South Africa: estimated cost and cost-effectiveness 2011-2050. PLoS One (2012) 2.39
Malaria control and elimination in Sri Lanka: documenting progress and success factors in a conflict setting. PLoS One (2012) 2.34
A test-based strategy is more cost effective than empiric dose escalation for patients with Crohn's disease who lose responsiveness to infliximab. Clin Gastroenterol Hepatol (2013) 2.31
Estimating the resources needed and savings anticipated from roll-out of adult male circumcision in Sub-Saharan Africa. PLoS One (2008) 2.31
Effect of race and/or ethnicity in use of antiretrovirals and prophylaxis for opportunistic infection: a review of the literature. Public Health Rep (2002) 2.14
Rapid implementation of an integrated large-scale HIV counseling and testing, malaria, and diarrhea prevention campaign in rural Kenya. PLoS One (2010) 2.12
The effect of health insurance on medical care utilization and implications for insurance expansion: a review of the literature. Med Care Res Rev (2005) 2.11
Use of cost-effectiveness analysis to evaluate new technologies in orthopaedics. The case of alternative bearing surfaces in total hip arthroplasty. J Bone Joint Surg Am (2006) 2.07
Assessing the efficiency of HIV prevention around the world: methods of the PANCEA project. Health Serv Res (2004) 1.96
The cost effectiveness of home-based provision of antiretroviral therapy in rural Uganda. Appl Health Econ Health Policy (2009) 1.94
Text messaging to improve attendance at post-operative clinic visits after adult male circumcision for HIV prevention: a randomized controlled trial. PLoS One (2012) 1.85
Highly active antiretroviral treatment as prevention of HIV transmission: review of scientific evidence and update. Curr Opin HIV AIDS (2010) 1.83
HIV prevention programmes for female sex workers in Andhra Pradesh, India: outputs, cost and efficiency. BMC Public Health (2005) 1.83
Outputs, cost and efficiency of public sector centres for prevention of mother to child transmission of HIV in Andhra Pradesh, India. BMC Health Serv Res (2008) 1.69
Cost and efficiency of public sector sexually transmitted infection clinics in Andhra Pradesh, India. BMC Health Serv Res (2005) 1.66
Taking ART to scale: determinants of the cost and cost-effectiveness of antiretroviral therapy in 45 clinical sites in Zambia. PLoS One (2012) 1.57
Preventing the reintroduction of malaria in Mauritius: a programmatic and financial assessment. PLoS One (2011) 1.40
Changing cost of HIV interventions in the context of scaling-up in India. AIDS (2008) 1.39
A model of transluminal flow of an anti-HIV microbicide vehicle: Combined elastic squeezing and gravitational sliding. Phys Fluids (1994) (2008) 1.31
Two- to sixfold decreased odds of HIV risk behavior associated with use of syringe exchange. J Acquir Immune Defic Syndr (2002) 1.30
Estimation of unmet need for HIV primary medical care: a framework and three case studies. AIDS Educ Prev (2005) 1.27
Cost-effectiveness of cotrimoxazole prophylaxis among persons with HIV in Uganda. J Acquir Immune Defic Syndr (2007) 1.20
Gestational diabetes mellitus: results from a survey of country prevalence and practices. J Matern Fetal Neonatal Med (2011) 1.19
The cost of a rapid-test VCT clinic in South Africa. S Afr Med J (2005) 1.15
"Before we used to get sick all the time": perceptions of malaria and use of long-lasting insecticide-treated bed nets (LLINs) in a rural Kenyan community. Malar J (2010) 1.12
The cost-effectiveness of gestational diabetes screening including prevention of type 2 diabetes: application of a new model in India and Israel. J Matern Fetal Neonatal Med (2013) 1.10
The costs and benefits of private sector provision of treatment to HIV-infected employees in Kampala, Uganda. AIDS (2006) 1.10
The effects of inhomogeneous boundary dilution on the coating flow of an anti-HIV microbicide vehicle. Phys Fluids (1994) (2011) 1.08
Scaling up prevention of mother-to-child HIV transmission programs in sub-Saharan African countries: a multilevel assessment of site-, program- and country-level determinants of performance. BMC Public Health (2013) 1.08
Melatonin entrains free-running blind people according to a physiological dose-response curve. Chronobiol Int (2005) 1.03
Circadian uses of melatonin in humans. Chronobiol Int (2006) 0.98
The impact of male circumcision on HIV transmission. J Urol (2010) 0.97
Effect of text messaging to deter early resumption of sexual activity after male circumcision for HIV prevention: a randomized controlled trial. J Acquir Immune Defic Syndr (2014) 0.96
Phase angle of entrainment in morning- and evening-types under naturalistic conditions. Chronobiol Int (2009) 0.95
Peering into the black box: billing and insurance activities in a medical group. Health Aff (Millwood) (2009) 0.93
Responding to racial and ethnic disparities in use of HIV drugs: analysis of state policies. Public Health Rep (2002) 0.93
Use of the non-pneumatic anti-shock garment (NASG) for life-threatening obstetric hemorrhage: a cost-effectiveness analysis in Egypt and Nigeria. PLoS One (2013) 0.92
Development of a model to assess the cost-effectiveness of gestational diabetes mellitus screening and lifestyle change for the prevention of type 2 diabetes mellitus. Int J Gynaecol Obstet (2011) 0.91
The phase shift hypothesis for the circadian component of winter depression. Dialogues Clin Neurosci (2007) 0.91
Health state utility in patients with osteoarthritis of the hip and total hip arthroplasty. J Arthroplasty (2011) 0.91
Patient preferences and willingness to pay for arthroplasty surgery in patients with osteoarthritis of the hip. J Arthroplasty (2011) 0.90
Use of measles supplemental immunization activities (SIAs) as a delivery platform for other maternal and child health interventions: opportunities and challenges. Vaccine (2012) 0.89
Cost-effectiveness of home-based chlorination and safe water storage in reducing diarrhea among HIV-affected households in rural Uganda. Am J Trop Med Hyg (2006) 0.85
Case management to improve adherence for HIV-infected patients receiving antiretroviral therapy in Ethiopia: a micro-costing study. Cost Eff Resour Alloc (2011) 0.85
Harnessing the prevention benefits of antiretroviral therapy to address HIV and tuberculosis. Curr HIV Res (2011) 0.84
Implementation and Operational Research: Cost and Efficiency of a Hybrid Mobile Multidisease Testing Approach With High HIV Testing Coverage in East Africa. J Acquir Immune Defic Syndr (2016) 0.83
A qualitative assessment of beliefs, attitudes, and behaviors related to diarrhea and water filtration in rural Kenya. Am J Public Health (2011) 0.83
Evaluation of impact of long-lasting insecticide-treated bed nets and point-of-use water filters on HIV-1 disease progression in Kenya. AIDS (2013) 0.83
Saving lives and saving money: hospital-based violence intervention is cost-effective. J Trauma Acute Care Surg (2015) 0.83
Projections for Achieving the Lancet Commission Recommended Surgical Rate of 5000 Operations per 100,000 Population by Region-Specific Surgical Rate Estimates. World J Surg (2015) 0.83
Sexually transmitted infections among HIV-infected adults in HIV care programs in Kenya: a national sample of HIV clinics. Sex Transm Dis (2013) 0.82
Costing human rights and community support interventions as a part of universal access to HIV treatment and care in a Southern African setting. Curr HIV Res (2011) 0.82
Stigma in Ethiopia: association with depressive symptoms in people with HIV. AIDS Care (2014) 0.82
Preventing HIV in injection drug users: choosing the best mix of interventions for the population. J Urban Health (2003) 0.80
Adult male circumcision in Nyanza, Kenya at scale: the cost and efficiency of alternative service delivery modes. BMC Health Serv Res (2014) 0.79
Viral load monitoring for antiretroviral therapy in resource-poor settings: an evolving role. AIDS (2013) 0.79
Integrated disease prevention campaigns: assessing country opportunity for implementation via an index approach. BMJ Open (2014) 0.76
Treatment-centred prevention: an integrated biomedical and social approach to HIV prevention. AIDS (2011) 0.75
Billing and insurance-related administrative costs in United States' health care: synthesis of micro-costing evidence. BMC Health Serv Res (2014) 0.75
Cost-Effectiveness of Direct-Acting Anti-viral Treatment in Hepatitis C-infected Liver Transplant Candidates with Compensated Cirrhosis and Hepatocellular Carcinoma. Transplantation (2016) 0.75
Prevalence and correlates of insecticide-treated bednet use among HIV-1-infected adults in Kenya. AIDS Care (2012) 0.75
Correction: Cost-Effectiveness Of Treatment Strategies for BRAF-Mutated Metastatic Melanoma. PLoS One (2015) 0.75
Increasing access to care for the uninsured: considering the options in California counties. J Health Care Poor Underserved (2006) 0.75
MSJAMA: Government share of health care expenditures. JAMA (2003) 0.75
Cost and efficiency of a hybrid mobile multi-disease testing approach with high HIV testing coverage in East Africa. J Acquir Immune Defic Syndr (2016) 0.75